Inventor · disambiguated record
Yuan Lin
Also filed as: LIN YUAN · LIN YUAN-FENG
26 granted patents·15 pending applications·493 citations·filing 1990–2022
96Inventor score
Files withALLERGAN INC9GUANGZHOU VIROTECH PHARMACEUTICAL CO LTD7JIANGSU HENGRUI PHARMACEUTICALS CO LTD5ALLERGAN SALES INC3JIANGSU HENGRUI MEDICINE CO2
Top patents by PatentIndex Score
41 records- 0197US5514825AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted May 7, 1996·87 cites·17 claims
- 0296US5543534AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activityALLERGAN INC·Filed 1994·Granted Aug 6, 1996·81 cites·23 claims
- 0393US5763635ATetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 1996·Granted Jun 9, 1998·54 cites·36 claims
- 0493US5654469AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Aug 5, 1997·49 cites·35 claims
- 0593US5591858AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activityALLERGAN INC·Filed 1996·Granted Jan 7, 1997·61 cites·19 claims
- 0690US6344561B2O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN SALES INC·Filed 2000·Granted Feb 5, 2002·16 cites·15 claims
- 0790US5998655AAlkylidene substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityFiled 1998·Granted Dec 7, 1999·38 cites·23 claims
- 0884US5741896AO- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 1996·Granted Apr 21, 1998·22 cites·31 claims
- 0981US5723620AAcetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activityALLERGAN INC·Filed 1995·Granted Mar 3, 1998·18 cites·18 claims
- 1080US8901132B2Thiazolopyrimidine modulators as immunosuppressive agentsHERDEWIJN PIET·Filed 2010·Granted Dec 2, 2014·7 cites·16 claims
- 1175US11234968B2Use of VCP inhibitor and oncolytic virus in the preparation of an anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Granted Feb 1, 2022·1 cites·12 claims
- 1273US9221822B2Thiazolopyrimidine modulators as immunosuppressive agentsUNIV LEUVEN KATH·Filed 2014·Granted Dec 29, 2015·2 cites·8 claims
- 1372US6187933B1O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN SALES INC·Filed 2000·Granted Feb 13, 2001·3 cites·18 claims
- 1468US10517909B2Use of alphavirus in preparation of antitumor drugsGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2015·Granted Dec 31, 2019·1 cites·45 claims
- 1566US6465663B2O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 2001·Granted Oct 15, 2002·2 cites·11 claims
- 1666US6051731AO-or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN SALES INC·Filed 1997·Granted Apr 18, 2000·7 cites·39 claims
- 1766US5034419AN-cycloalkylalkylamines, process for their preparation, their use as medicament and their synthesis intermediatesOREAL·Filed 1990·Granted Jul 23, 1991·18 cites·8 claims
- 1862US12398353B2Full-ocean-depth fidelity enzymological measurement device for microbial extracellular enzymesUNIV SHANGHAI OCEAN·Filed 2022·Granted Aug 26, 2025·0 cites·9 claims
- 1958US11235011B2Use of alphavirus in preparation of antitumor drugsGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 1, 2022·0 cites·20 claims
- 2056US2025340661A1Anti cd40 antibody, antigen binding fragment and medical use thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2154US10793460B2Glass forming furnaceCBASE TECH CO LTD·Filed 2018·Granted Oct 6, 2020·0 cites·8 claims
- 2254US6025400ACompositions for treatment of antibiotic-resistant gram-positive bacterial infections and methods for using and preparing the sameMARCO POLO TECHNOLOGIES·Filed 1998·Granted Feb 15, 2000·15 cites·11 claims
- 2354US2024075158A1Complex of anti-il-4r antibody or antigen-binding fragment thereof and medical use thereofJIANGSU HENGRUI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2454US2024376204A1Protein specifically binding to pd-1 and pharmaceutical use thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2554US2022056094A1Human interleukin-2 variant or derivative thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 2653US10980850B2Use of IAP inhibitor and oncolytic virus in preparation of anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Granted Apr 20, 2021·0 cites·13 claims
- 2753US2025051467A1Fap/cd40 binding molecule and medicinal use thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2850US6855832B2O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activityALLERGAN INC·Filed 2002·Granted Feb 15, 2005·0 cites·14 claims
- 2950US2024043530A1PVRIG Binding Protein And Its Medical UsesJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3049US5017723ASubstituted ethylamines, their preparation process, their use as medicine and their synthesising agentsJOUVEINAL SA·Filed 1990·Granted May 21, 1991·4 cites·6 claims
- 3149US2023089620A1Anti-IL-2 Antibody, and Antigen-Binding Fragment Thereof and Medical Use ThereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3249US2021380680A1Anti-claudin antibodies and uses thereofZLLP HOLDING LTD·Filed 2019·Application pending·0 cites
- 3348US2022025060A1Anti-cd40 antibody, antigen binding fragmentand pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 3447US2019388441A1Novel prodrugs of mizoribineUNIV LEUVEN KATH·Filed 2018·Application pending·0 cites
- 3546US2021228660A1Use of proteasome inhibitor and alphavirus in preparation of anti-tumor medicamentGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 3643US2020405793A1Use of mevalonate metabolic pathway inhibitor and alphavirus in preparing anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 3741US6316033B1Compositions for treatment of antibiotic-resistant gram-positive bacterial infections and methods for using and preparing the sameMARCO POLO TECHNOLOGIES·Filed 1999·Granted Nov 13, 2001·6 cites·20 claims
- 3841US2019183948A1Use of bcl-xl inhibitor and oncolytic virus in preparation of antitumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 3940US2013089854A1Kit for dot immunogold directed filtration assay and use thereofLIN YUAN·Filed 2010·Application pending·0 cites
- 4036US2009028830A1Preparation of multipotent stem cells and the use thereofLIU YUNG-HSIANG·Filed 2006·Application pending·0 cites
- 4133US5089639AN-cycloalkylalkylamines, process for their preparation, their use as a medicament and their synthesis intermediatesJOUVEINAL SA·Filed 1991·Granted Feb 18, 1992·1 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Yuan Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →